Key Dates

Related Announcements

PAR-21-203 - Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this Notice is to inform applicants of the topic areas for the June 21, 2021 due date of the NCATS CTSA Program funding opportunity announcement (FOA) PAR-21-203, Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed) .

Background

Through this notice, NCATS will support applications for Clinical and Translational Science Award (CTSA) Program consortium-wide resource centers that will rapidly demonstrate and disseminate innovative resources (to include capabilities) that have demonstrated impact at a local or national level to the wider consortium. Applicants must address one but not both of the topics below.

Health Informatics: Solutions to enhance clinical research, including the ability to collect and analyze large data sets and implement innovative informatics solutions that improve human health.

Examples:

• Dissemination of enhanced interoperability of different types of data: imaging, -omics, Electronic Health Records (EHR), mobile platforms, waveforms
• Dissemination of data standards, e.g., messaging standards such as HL7 FHIR; Ontological / Value sets standard such as ICD, RxNorm, LOINC
• Development and dissemination of quality improvements in research data warehouses to ensure clinical and/or public health data is interoperable (standard datasets e.g. ICD, RxNORM, LOINC), available and complete
• Development and dissemination of open-source software, tools, and algorithms that are generalizable, transparent, and include bench marking and methodological reproducibility; and are usable within the NCATS/CTSA enterprise Shared Cloud Based Ecosystem
• Cutting-edge informatics research in emerging technologies that are expected to facilitate and speed clinical research, e.g., machine learning (ML), natural language processing (NLP), Patient Reported Outcomes (PROs), and digital protocols; and dissemination of solutions

It is expected that all projects will promote Open Science (FAIR) Data Sharing; Privacy and Security Standards; Attribution, Reproductivity, Transparency, Generalizability, and Best Practices; and Enterprise Maturity Standards for next generation clinical research.

Demonstrating Research Impact: Leveraging innovative approaches to assess, quantify, and communicate research impact for large networks.

Applications that do not address one of the two research areas stated above will be considered non-responsive to the NOSI and withdrawn without review.

Application and Submission Information

This notice applies to the June 21, 2021 due date for the following FOA:

• PAR-21-203 - Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)

All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:

• For funding consideration, applicants must include NOT-TR-21-025 (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.

Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.

Inquiries